The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: Interim Results after Two Years of Treatment-Reference-Cited by-同舟云学术

The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: Interim Results after Two Years of Treatment

Published:2014-09-02 Issue:s3 Volume:42 Page:S281-S288
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Amenta Francesco¹,Carotenuto Anna¹,Fasanaro Angiola Maria²,Rea Raffaele¹,Traini Enea¹

Affiliation:

1. Centro Ricerche Cliniche, Scienze del Farmaco e dei Prodotti della Salute, Università di Camerino, Camerino, Italy

2. Unità Valutativa Alzheimer e Malattie Involutive Cerebrali, Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli, Napoli, Italy

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dementia after Ischemic Stroke, from Molecular Biomarkers to Therapeutic Options;International Journal of Molecular Sciences;2024-07-16

2. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial;Medicine;2024-06-14

3. Cognitive disorders and dysphagia in the elderly: A review;Consilium Medicum;2024-05-09

4. Choline alfoscerate in the correction of cognitive impairment;Neurology, Neuropsychiatry, Psychosomatics;2023-12-17

5. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis;Journal of Alzheimer's Disease;2023-03-07